ULURU Grants Discus Dental Sole U.S. Distribution Rights for Aphthasol, the FDA Approved Prescription Drug for Aphthous Ulcers; Discus Dental to Promote to Consumers and Dental Professionals.DALLAS -- ULURU Inc. ("ULURU") who has signed a definitive merger agreement with Oxford Ventures, Inc. (OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. : OXFV) today announced that Discus Dental has been granted the sole distribution rights for Aphthasol in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . In extensive clinical studies Aphthasol has been proven effective in accelerating the healing of aphthous ulcers and reducing the pain associated with the condition. Clinical studies have also shown that the ulcerative ulcerative /ul·cer·a·tive/ (ul´se-ra?tiv) (ul´ser-ah-tiv) pertaining to or characterized by ulceration. ulcerative pertaining to or characterized by ulceration. phase of the disease can be aborted if the product is used at the first sign or symptom of the disease. Aphthasol was the first prescription product approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. to treat aphthous ulcers. Subsequently, approval has been granted by the FDA for OraDisc A which incorporates the same active that is in Aphthasol in an erodible mucoadhesive film. This product has also been licensed to Discus Dental. "This agreement will allow us to leverage our strengths within the dental industry to effectively create awareness and adoption of this breakthrough product and provide the millions of canker sore canker sore n. A small painful ulcer of the mucous membrane of the mouth; an aphtha. Also called aphthous stomatitis, recurrent aphthous ulcers, ulcerative stomatitis. sufferers with a proven treatment," explained Brendan McLoughlin, Vice President and General Manager of Pharmaceutical & Consumer Products, Discus Dental. Under the terms of the agreement with Discus Dental, ULURU will receive royalties on the sales of Aphthasol. In addition on the launch of OraDisc A, Discus Dental will pay a licensing fee and make further milestone payments based upon the commercial success of the product. "With their exceptional record marketing products to the dental professionals and their consumer marketing expertise Discus Dental is the ideal partner to market Aphthasol," commented Kerry P. Gray, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of ULURU Inc. "Extensive market research clearly indicates that there is a significant market opportunity for an effective product that can accelerate the healing of aphthous ulcers and reduce the pain associated with the disease. We look forward to working with Discus Dental to maximize this product opportunity." ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of topical delivery technologies including its innovative transmucosal delivery system and Hydrogel hy·dro·gel n. A colloidal gel in which the particles are dispersed in water. hydrogel a gel that contains water. hydrogel Wound care A polymer absorptive wound dressing. See Dressing. Nanoparticle Aggregate Technology to provide patients and consumers with an improved clinical outcome through controlled drug delivery. Discus Dental: Founded in 1993, Discus Dental, Inc. is a leader in the marketing and worldwide distribution of clinical and premium aesthetic products to dental professionals and direct to consumers. The company also provides practice management software, practice building tools, and services as well as expert industry training for the dental community. Discus Dental is headquartered in Culver City, California Culver City is a city in western Los Angeles County, California. As of the 2000 census, the city had a population of 38,816. The community is mostly surrounded by the city of Los Angeles but also has a border with unincorporated areas of Los Angeles County. . More information is available at www.discusdental.com |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion